Invention Grant
- Patent Title: Apoptosis signal-regulating kinase inhibitor
-
Application No.: US15140204Application Date: 2016-04-27
-
Publication No.: US09750730B2Publication Date: 2017-09-05
- Inventor: Gregory Notte
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: GILEAD SCIENCES, INC.
- Current Assignee: GILEAD SCIENCES, INC.
- Current Assignee Address: US CA Foster City
- Agent Briana R. Barron
- Main IPC: A61K31/44
- IPC: A61K31/44 ; C07D213/56 ; A61K31/4439 ; C07D401/14 ; C07D233/56 ; C07D401/04 ; A61K9/00 ; A61K9/20 ; A61K45/06
Abstract:
The present invention relates to a compound of formula (I): The compound has apoptosis signal-regulating kinase (“ASK1”) inhibitory activity, and is thus useful in the treatment of diseases such as kidney disease, diabetic nephropathy and kidney fibrosis.
Public/Granted literature
- US20160235728A1 APOPTOSIS SIGNAL-REGULATING KINASE INHIBITOR Public/Granted day:2016-08-18
Information query
